Jove
Visualize
Contact Us

Related Experiment Videos

Thyroid cancer in children.

Catherine Dinauer1, Gary L Francis

  • 1Department of Pediatrics, Yale School of Medicine, P.O. Box 208081, 464 Congress Avenue, New Haven, CT 06520-8081, USA.

Endocrinology and Metabolism Clinics of North America
|August 4, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of disparities in the incidence, presentation, and treatment of pediatric differentiated thyroid cancer in the United States (2000-2022).

PloS one·2025
Same author

Perinatal Exposures to Ambient Fine Particulate Matter and Outdoor Artificial Light at Night and Risk of Pediatric Papillary Thyroid Cancer.

Environmental health perspectives·2025
Same author

An Infant With <i>DHX37</i> Variant: A Novel Etiology of 46,XY DSD and Literature Review.

JCEM case reports·2024
Same author

Differences in the management of thyroid nodules in children and adolescents as compared to adults.

Current opinion in endocrinology, diabetes, and obesity·2022
Same author

Treatment of hypothyroidism in infants, children and adolescents.

Trends in endocrinology and metabolism: TEM·2022
Same author

Shear wave elastography reveals a high prevalence of liver fibrosis in overweight or obese Hispanic youth.

Journal of ultrasonography·2020
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Childhood thyroid cancer differs from adult types, showing unique genetic mutations and robust immune responses. Further research is needed for risk stratification and managing specific cases, especially in young children.

Area of Science:

  • Pediatric Oncology
  • Endocrinology
  • Immunology

Background:

  • Thyroid cancer in children is uncommon but presents unique characteristics compared to adult forms.
  • Significant advancements have been made in understanding childhood thyroid cancer over the past decade.
  • Differences in genetic mutations and growth factor expression are noted between pediatric and adult thyroid cancers.

Purpose of the Study:

  • To update the understanding of pediatric thyroid cancer, incorporating recent findings.
  • To relate current knowledge to the American Thyroid Association's management guidelines for thyroid cancer.
  • To review the limited data on managing children with detectable thyroglobulin and negative imaging.

Main Methods:

  • Review of scientific literature on childhood thyroid cancer.

Related Experiment Videos

  • Analysis of genetic mutations and growth factor expression patterns.
  • Comparison of pediatric and adult thyroid cancer characteristics.
  • Evaluation of immune response in pediatric thyroid cancer.
  • Main Results:

    • Childhood thyroid cancers exhibit distinct genetic and growth factor profiles compared to adult cancers.
    • A robust immune response in children may contribute to better longevity.
    • Children under 10 years old may be a high-risk group for persistent or recurrent disease.
    • Knowledge gaps exist in risk stratification and managing specific clinical scenarios.

    Conclusions:

    • Pediatric thyroid cancer has unique biological features influencing its course.
    • Management strategies need refinement, particularly for high-risk pediatric subgroups.
    • Further research is essential to address current limitations in diagnosis and treatment stratification.